Table 1.
Demographic and post-mortem characteristics of control and DLB groups.
| Variable | Controls (n = 29) | DLB (n = 30) | P value |
|---|---|---|---|
| Age (mean years ±SD) | 79.4 ± 8.0 | 77.6 ± 8.3 | 0.397a |
| Gender (male:female) | 17:12 | 24:6 | 0.075b |
| Post-mortem delay (mean hours ±SD) | 33.9 ± 15.5 | 27.3 ± 14.6 | 0.096a |
| Braak P-tau stage | |||
| Not available | 1 | 3 | 0.235b |
| 0 | 7 | 6 | |
| I | 6 | 4 | |
| II | 12 | 8 | |
| III | 3 | 9 | |
| IV–VI | 0 | 0 | |
Braak P-tau stage unavailable in four cases (three DLB, one control), but neuropathological reports supported no significant co-existing AD pathology. Statistical tests: aindependent samples t test; bPearson Chi-squared. Significant results (P < 0.05) in italic (none).